Skip to main content

Ironwood Pharmaceuticals Inc

IRWD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001446847

In the last 90 days, Ironwood Pharmaceuticals Inc insiders filed 0 open-market purchases and 1 sale; 212 institutions reported holding it in 13F filings for Q2 2026, worth $675.8M in total; no superinvestor holds it.

Members of Congress who traded IRWD

No member of Congress has reported a trade in Ironwood Pharmaceuticals Inc since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.